Katarzyna Kowanetz

发表

Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors

Anneleen Daemen, Deepak Sampath, Gerard Manning, 2015, Proceedings of the National Academy of Sciences.

Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor β Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase*

C. Heldin, A. Moustakas, Katarzyna Kowanetz, 2012, The Journal of Biological Chemistry.

Suppressors of T-cell Receptor Signaling Sts-1 and Sts-2 Bind to Cbl and Inhibit Endocytosis of Receptor Tyrosine Kinases*

C. Heldin, I. Dikic, Mirko H. H. Schmidt, 2004, Journal of Biological Chemistry.

Dab2 links CIN85 with clathrin‐mediated receptor internalization

I. Dikic, Katarzyna Kowanetz, J. Terzic, 2003, FEBS letters.

IdentificationofPreferredChemotherapeuticsforCombining with a CHK1 Inhibitor

Marie Evangelista, S. Malek, P. Jackson, 2013 .

Jcb: Report

C. Heldin, A. Moustakas, Katarzyna Kowanetz, 2022 .

Identification of a Novel Proline-Arginine Motif Involved in CIN85-dependent Clustering of Cbl and Down-regulation of Epidermal Growth Factor Receptors*

J. Ladbury, I. Dikic, Katarzyna Kowanetz, 2003, Journal of Biological Chemistry.

Identification of a novel proline-arginine motif involved in CIN85-dependent clustering of Cbl and downregulation of EGF receptors

J. Ladbury, I. Dikic, Katarzyna Kowanetz, 2003 .

erratum: Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors

I. Dikic, W. Langdon, Katarzyna Kowanetz, 2002, Nature.

Cbl–CIN85–endophilin complex mediates ligand-induced downregulation of EGF receptors

I. Dikic, W. Langdon, Katarzyna Kowanetz, 2002, Nature.

Regulation of ubiquitin-binding proteins by monoubiquitination

Sebastian A. Wagner, M. Mann, R. Breitling, 2006, Nature Cell Biology.

Identification of Preferred Chemotherapeutics for Combining with a CHK1 Inhibitor

Thomas V. O'brien, S. Malek, P. Jackson, 2013, Molecular Cancer Therapeutics.

Small Molecule Therapeutics Identi fi cationof PreferredChemotherapeutics forCombining with a CHK 1 Inhibitor

S. Malek, P. Jackson, Katarzyna Kowanetz, 2013 .

Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1366 Adaptor Proteins in Regulation of Receptor Endocytosis

Katarzyna Kowanetz, 2004 .

Adaptor Proteins in Regulation of Receptor Endocytosis

Katarzyna Kowanetz, 2004 .

CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.

P. De Camilli, K. Pavelić, Mirko H. H. Schmidt, 2004, Molecular biology of the cell.

CIN85 Participates in Cbl-b-mediated Down-regulation of Receptor Tyrosine Kinases*

Ivan Dikic, S. Lipkowitz, Katarzyna Kowanetz, 2002, The Journal of Biological Chemistry.

Combination Drug Scheduling Defines a “Window of Opportunity” for Chemopotentiation of Gemcitabine by an Orally Bioavailable, Selective ChK1 Inhibitor, GNE-900

Ivana Yen, S. Malek, T. O'Brien, 2013, Molecular Cancer Therapeutics.

Small Molecule Therapeutics Combination Drug Scheduling De fi nes a " Window of Opportunity " for Chemopotentiation of Gemcitabine by an Orally Bioavailable , Selective ChK 1 Inhibitor , GNE-900

Ivana Yen, S. Malek, T. O'Brien, 2013 .

Loss of T-Cell Protein Tyrosine Phosphatase Induces Recycling of the Platelet-derived Growth Factor (PDGF) β-Receptor but Not the PDGF α-Receptor

C. Heldin, C. Hellberg, Katarzyna Kowanetz, 2006 .

Loss of T-Cell Protein Tyrosine Phosphatase Induces Recycling of the Platelet-derived Growth Factor (PDGF) (cid:1) -Receptor but Not the PDGF (cid:2) -Receptor □ D

C. Heldin, C. Hellberg, Katarzyna Kowanetz, 2006 .

CIN 85 participates in Cbl-b-mediated downregulation of receptor tyrosine kinases

S. Lipkowitz, Katarzyna Kowanetz, P. Soubeyran, 2002 .

Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor.

C. Heldin, C. Hellberg, Katarzyna Kowanetz, 2006, Molecular biology of the cell.

Transcriptional Induction of Salt-inducible Kinase 1 by Transforming Growth Factor β Leads to Negative Regulation of Type I Receptor Signaling in Cooperation with the Smurf2 Ubiquitin Ligase*

C. Heldin, A. Moustakas, Katarzyna Kowanetz, 2012, The Journal of Biological Chemistry.

Identification of Preferred Chemotherapeutics for Combining with a CHK1 Inhibitor

S. Malek, P. Jackson, Katarzyna Kowanetz, 2013, Molecular Cancer Therapeutics.

TGFβ induces SIK to negatively regulate type I receptor kinase signaling

C. Heldin, A. Moustakas, Katarzyna Kowanetz, 2008, The Journal of cell biology.